<DOC>
	<DOCNO>NCT00748150</DOCNO>
	<brief_summary>Annual trial registration influenza vaccine strain composition season 2008/2009</brief_summary>
	<brief_title>Safety Immunogenicity Influenza Vaccine ( Surface Antigen , Inactivated ) Ph.Eur , Formulation 2008-2009 , When Administered Non-Elderly Adult Elderly Subjects</brief_title>
	<detailed_description>At enrolment , subject stratify two age stratum ( 18 60 year , 60 year ) . Total duration study three week . Vaccinations administer day 1 . Blood sample collect day 1 ( baseline , vaccination ) day 22 ( three week vaccination ) . Sera test Hemagglutination Inhibition ( HI ) assay . Safety assess 3 week vaccination .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>≥ 18 year age , mentally competent , willing able give inform consent prior study entry available visit schedule study able comply study requirement good health determine : 1. medical history 2. physical examination 3. clinical judgment investigator Any serious ( judgment investigator ) disease include , limited : 1 . Cancer , except localize skin cancer 2 . Advanced congestive heart failure 3 . Chronic obstructive pulmonary disease ( COPD 4 . Autoimmune disease ( include rheumatoid arthritis ) 5 . Acute progressive hepatic disease 6 . Acute progressive renal disease 7 . Severe neurological psychiatric disorder 8 . Severe asthma History anaphylactic reaction and/or serious allergic reaction follow vaccination , proven hypersensitivity component study vaccine ( e.g . ovalbumin , chicken protein , chicken feather , influenza viral protein , neomycin , polymixin ) Known suspect ( high risk develop ) impairment/alteration immune function ( exclude normally associate advanced age ) result example : 1 . Receipt immunosuppressive therapy ( parenteral oral corticosteroid cancer chemotherapy/radiotherapy ) within past 60 day full length study 2 . Receipt immunostimulants , 3 . Receipt parenteral immunoglobulin preparation , blood product , and/or plasma derivative within past 3 month full length study , 4 . Suspected known HIV infection HIVrelated disease . Known suspected history drug alcohol abuse . The subject bleeding diathesis condition associate prolonged bleeding time investigator 's opinion would interfere safety subject Women pregnant woman childbearing potential unwilling practice acceptable contraception duration study ( 21 day ) . Influenza vaccination laboratory confirm influenza within last 6 month one influenza vaccination within past 12 month Within past 4 week , subject receive : 1. another vaccine 2. investigational agent Any acute chronic infection require systemic antibiotic treatment antiviral therapy within last 7 day . The subject experience acute exacerbation COPD within past 14 day The subject experience fever ( i.e . axillary temperature ³ 38.0°C ) within last 3 day Severely obese Body Mass Index ( BMI ) &gt; 35 kg/m2 Any condition , , opinion investigator , might prevent subject participation interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>flu</keyword>
	<keyword>influenza</keyword>
	<keyword>influenza vaccine antigen</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>antibody response</keyword>
	<keyword>intra muscular</keyword>
	<keyword>elderly</keyword>
	<keyword>non-elderly</keyword>
</DOC>